|
x |
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
|
o |
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT
|
Argan,
Inc.
|
(Exact
Name of registrant as Specified in Its
Charter)
|
Delaware
|
13-1947195
|
(State
or other Jurisdiction of Incorporation
or
Organization)
|
(I.R.S.
Employer Identification No.)
|
One
Church Street, Suite 401,
Rockville MD 20850
|
(Address
of Principal Executive Offices) (Zip
Code)
|
(301)
315-0027
|
(Registrant’s
telephone number, including area
code)
|
(Former
Name, Former Address and Former Fiscal Year,
if
Changed Since Last Report)
|
Large accelerated filer o | Accelerated filer o | Non-accelerated filer þ |
Page
No.
|
||
PART
I. FINANCIAL INFORMATION
|
3
|
|
|
||
Item
1.
|
Financial
Statements (unaudited)
|
3
|
|
||
Condensed
Consolidated Balance Sheets - April 30, 2007 and January 31,
2007
|
3
|
|
|
||
Condensed
Consolidated Statements of Operations for the Three Months
|
|
|
|
Ended
April 30, 2007 and 2006
|
4
|
|
||
Condensed
Consolidated Statements of Cash Flows for the Three Months
|
|
|
|
Ended
April 30, 2007 and 2006
|
5
|
|
||
Notes
to Condensed Consolidated Financial Statements
|
6
|
|
|
||
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition
|
|
and
Results of Operation
|
11
|
|
|
||
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
21
|
|
||
Item
4.
|
Controls
and Procedures
|
21
|
|
||
PART
II. OTHER INFORMATION
|
21
|
|
|
||
Item
1.
|
Legal
Proceedings
|
21
|
|
||
Item
1a.
|
Risk
Factors
|
22
|
|
||
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
22
|
|
||
Item
3.
|
Defaults
Upon Senior Securities
|
22
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
22
|
|
||
Item
5.
|
Other
Information
|
22
|
|
||
Item
6.
|
Exhibits
|
22
|
|
||
SIGNATURES
|
23
|
ARGAN,
INC.
|
|||||||
Condensed
Consolidated Balance Sheets
|
|||||||
(Unaudited)
|
|||||||
April
30,
|
January
31,
|
||||||
2007
|
2007
|
||||||
ASSETS
|
|||||||
CURRENT
ASSETS:
|
|||||||
Cash
and cash equivalents
|
$
|
32,640,000
|
$
|
25,393,000
|
|||
Accounts
receivable, net of allowance for doubtful accounts of
$213,000
|
|||||||
at
4/30/07 and $137,000 at 1/31/2007
|
23,266,000
|
23,030,000
|
|||||
Receivable
from affiliated entity
|
146,000
|
155,000
|
|||||
Investments
available for sale
|
1,705,000
|
2,283,000
|
|||||
Escrowed
cash
|
15,196,000
|
15,031,000
|
|||||
Estimated
earnings in excess of billings
|
4,136,000
|
12,003,000
|
|||||
Current
deferred tax asset
|
959,000
|
-
|
|||||
Inventories,
net of reserves of $116,000 at 04/30/2007 and $104,000
|
|||||||
at
01/31/2007
|
2,640,000
|
2,387,000
|
|||||
Prepaid
expenses and other current assets
|
1,018,000
|
643,000
|
|||||
TOTAL
CURRENT ASSETS
|
81,706,000
|
80,925,000
|
|||||
Property
and equipment, net of accumulated depreciation of
|
|||||||
$2,656,000
at 4/30/2007 and $2,379,000 at 1/31/2007
|
3,070,000
|
3,250,000
|
|||||
Other
assets
|
276,000
|
313,000
|
|||||
Goodwill
|
23,981,000
|
23,981,000
|
|||||
Other
intangible assets, net
|
10,597,000
|
12,661,000
|
|||||
TOTAL
ASSETS
|
$
|
119,630,000
|
$
|
121,130,000
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable
|
$
|
42,755,000
|
$
|
44,248,000
|
|||
Due
to affiliates
|
35,000
|
7,000
|
|||||
Accrued
expenses
|
6,326,000
|
5,873,000
|
|||||
Estimated
loss on uncompleted contracts
|
189,000
|
-
|
|||||
Billings
in excess of cost and earnings
|
17,769,000
|
15,705,000
|
|||||
Current
portion of long-term debt
|
2,583,000
|
2,586,000
|
|||||
TOTAL
CURRENT LIABILITIES
|
69,657,000
|
68,419,000
|
|||||
Deferred
income tax liability
|
1,382,000
|
1,471,000
|
|||||
Other
liabilities
|
31,000
|
14,000
|
|||||
Long-term
debt
|
6,069,000
|
6,715,000
|
|||||
TOTAL
LIABILITIES
|
77,139,000
|
76,619,000
|
|||||
STOCKHOLDERS'
EQUITY
|
|||||||
Preferred
stock, par value $0.10 per share; 500,000 shares
authorized;
|
|||||||
no
shares issued and outstanding
|
-
|
-
|
|||||
Common
stock, par value $0.15 per share;
|
|||||||
12,000,000
shares authorized; 11,097,245 shares
|
|||||||
issued
at 4/30/2007 and 1/31/2007 and 11,094,012
|
|||||||
shares
outstanding at 4/30/2007 and 1/31/2007
|
1,664,000
|
1,664,000
|
|||||
Warrants
outstanding
|
849,000
|
849,000
|
|||||
Additional
paid-in capital
|
57,199,000
|
57,190,000
|
|||||
Accumulated
other comprehensive loss
|
(22,000
|
)
|
(8,000
|
)
|
|||
Accumulated
deficit
|
(17,166,000
|
)
|
(15,151,000
|
)
|
|||
Treasury
stock at cost; 3,233 shares at 4/30/2007 and 1/31/2007
|
(33,000
|
)
|
(33,000
|
)
|
|||
TOTAL
STOCKHOLDERS' EQUITY
|
42,491,000
|
44,511,000
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
119,630,000
|
$
|
121,130,000
|
|||
ARGAN,
INC.
|
|||||||
Condensed
Consolidated Statements of Operations
|
|||||||
(Unaudited)
|
|||||||
Three
months ended April 30,
|
|||||||
2007
|
|
2006
|
|||||
Net
sales
|
|||||||
Power
industry services
|
$
|
43,354,000
|
$
|
-
|
|||
Nutraceutical
products
|
4,949,000
|
5,829,000
|
|||||
Telecom
infrastructure services
|
2,129,000
|
3,133,000
|
|||||
Net
Sales
|
50,432,000
|
8,962,000
|
|||||
Cost
of sales
|
|||||||
Power
industry services
|
43,245,000
|
-
|
|||||
Nutraceutical
products
|
4,166,000
|
4,386,000
|
|||||
Telecom
infrastructure services
|
1,843,000
|
2,323,000
|
|||||
Gross
profit
|
1,178,000
|
2,253,000
|
|||||
Selling,
general and administrative expenses
|
4,561,000
|
1,976,000
|
|||||
(Loss)
income from operations
|
(3,383,000
|
)
|
277,000
|
||||
Interest
expense and amortization of
|
|||||||
subordinated
debt issuance costs
|
204,000
|
261,000
|
|||||
Other
income, net
|
(633,000
|
)
|
(2,000
|
)
|
|||
(Loss)
income from operations before
|
|||||||
income
taxes
|
(2,954,000
|
)
|
18,000
|
||||
Income
tax benefit (expense)
|
939,000
|
(36,000
|
)
|
||||
Net
loss
|
$
|
(2,015,000
|
)
|
$
|
(18,000
|
)
|
|
Basic
and diluted loss per share
|
$
|
(0.18
|
)
|
$
|
-
|
||
Weighted
average number of shares outstanding – basic and diluted
|
11,094,000
|
3,814,000
|
|||||
ARGAN,
INC.
|
|||||||
Condensed
Consolidated Statements of Cash
Flows
|
|||||||
(Unaudited)
|
|||||||
Three
Months ended April 30,
|
|||||||
2007
|
2006
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
loss
|
$
|
(2,015,000
|
)
|
$
|
(18,000
|
)
|
|
Adjustments
to reconcile net loss to net cash provided by operating
activities:
|
|||||||
Depreciation
and other amortization
|
324,000
|
247,000
|
|||||
Amortization
of debt issuance costs
|
-
|
129,000
|
|||||
Amortization
of purchased intangibles
|
2,064,000
|
331,000
|
|||||
Deferred
income taxes
|
(1,048,000
|
)
|
(39,000
|
)
|
|||
Non-cash
stock option compensation expense
|
14,000
|
-
|
|||||
Gain
on sale of property and equipment
|
(1,000
|
)
|
(2,000
|
)
|
|||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable, net
|
(236,000
|
)
|
(1,039,000
|
)
|
|||
Restricted
cash for surety bond
|
(165,000
|
)
|
-
|
||||
Estimated
earnings in excess of billings
|
7,867,000
|
505,000
|
|||||
Inventories,
net
|
(253,000
|
)
|
140,000
|
||||
Prepaid
expenses and other current assets
|
(375,000
|
)
|
(24,000
|
)
|
|||
Accounts
payable and accrued expenses
|
(1,040,000
|
)
|
620,000
|
||||
Billings
in excess of estimated earnings
|
2,064,000
|
31,000
|
|||||
Due
to (from) affiliates
|
37,000
|
(110,000
|
)
|
||||
Estimated
loss on uncompleted contracts
|
189,000
|
-
|
|||||
Other
|
(6,000
|
)
|
12,000
|
||||
Net
cash provided by operating activities
|
7,420,000
|
783,000
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Proceeds
from sale of investments
|
575,000
|
-
|
|||||
Proceeds
from sale of property and equipment
|
1,000
|
3,000
|
|||||
Purchases
of property and equipment
|
(100,000
|
)
|
(273,000
|
)
|
|||
Net
cash provided by (used in) investing activities
|
476,000
|
(270,000
|
)
|
||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Proceeds
from debt
|
2,112,000
|
1,605,000
|
|||||
Principal
payments on debt
|
(2,761,000
|
)
|
(2,030,000
|
)
|
|||
Net
cash used in financing activities
|
(649,000
|
)
|
(425,000
|
)
|
|||
NET
INCREASE IN CASH AND CASH EQUIVALENTS
|
7,247,000
|
88,000
|
|||||
CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
|
25,393,000
|
5,000
|
|||||
CASH
AND CASH EQUIVALENTS AT END OF PERIOD
|
$
|
32,640,000
|
$
|
93,000
|
|||
SUPPLEMENTAL
CASH FLOW INFORMATION
|
|||||||
Cash
paid for interest and income taxes is as follows:
|
|||||||
Interest
|
$
|
244,000
|
$
|
128,000
|
|||
Income
taxes
|
$
|
1,131,000
|
$
|
8,000
|
|||
Non-cash
investing and financing activities are as follows:
|
|||||||
Net
increase in unrealized investment loss
|
$
|
3,000
|
$
|
-
|
|||
Net
decrease in fair value of interest rate swaps
|
$
|
(17,000
|
)
|
$
|
-
|
||
April
30, 2007
|
January
31, 2007
|
||||||
Raw
materials
|
$
|
2,427,000
|
$
|
2,264,000
|
|||
Work-in
process
|
105,000
|
100,000
|
|||||
Finished
goods
|
224,000
|
127,000
|
|||||
Less:
Reserves
|
(116,000
|
)
|
(104,000
|
)
|
|||
Inventories,
net
|
$
|
2,640,000
|
$
|
2,387,000
|
Estimated
Useful Life
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying
Amount
|
||||||||||
Amortized
intangible assets:
|
|||||||||||||
Contractual
Customer
Relationships
|
5-7
years
|
$
|
2,854,000
|
$
|
1,589,000
|
$
|
1,265,000
|
||||||
Customer
Relationships - GPS
|
1-2
years
|
6,678,000
|
2,602,000
|
4,076,000
|
|||||||||
Proprietary
Formulas
|
3
years
|
1,813,000
|
1,660,000
|
153,000
|
|||||||||
Non-Compete
Agreement
|
5
years
|
2,334,000
|
1,002,000
|
1,332,000
|
|||||||||
Trade
Name - GPS
|
15
years
|
3,643,000
|
96,000
|
3,547,000
|
|||||||||
Unamortized
intangible assets:
|
|
||||||||||||
Trade
Name
|
Indefinite
|
224,000
|
--
|
224,000
|
|||||||||
Total
other intangible assets
|
$
|
17,546,000
|
$
|
6,949,000
|
$
|
10,597,000
|
|||||||
|
|||||||||||||
Goodwill
|
Indefinite
|
$
|
23,981,000
|
$
|
--
|
$
|
23,981,000
|
Power
Industry Services
|
|
Nutraceutical
Products
|
|
Telecom
Infrastructure
Services
|
|
Other
|
|
Consolidated
|
||||||||
Net
sales
|
$
|
43,354,000
|
$
|
4,949,000
|
$
|
2,129,000
|
$
|
--
|
$
|
50,432,000
|
||||||
Cost
of sales
|
43,245,000
|
4,166,000
|
1,843,000
|
--
|
49,254,000
|
|||||||||||
Gross
profit
|
109,000
|
783,000
|
286,000
|
--
|
1,178,000
|
|||||||||||
Selling,
general and administrative expenses
|
2,552,000
|
1,170,000
|
358,000
|
481,000
|
4,561,000
|
|||||||||||
Loss
from operations
|
(2,443,000
|
)
|
(387,000
|
)
|
(72,000
|
)
|
(481,000
|
)
|
(3,383,000
|
)
|
||||||
Interest
expense
|
(167,000
|
)
|
(35,000
|
)
|
(2,000
|
)
|
--
|
(204,000
|
)
|
|||||||
Other
income, net
|
626,000
|
--
|
--
|
7,000
|
633,000
|
|||||||||||
Loss
before income
taxes
|
$
|
(1,984,000
|
)
|
$
|
(422,000
|
)
|
$
|
(74,000
|
)
|
$
|
(474,000
|
)
|
(2,954,000
|
)
|
||
Income
tax benefit
|
939,000
|
|||||||||||||||
Net
loss
|
$
|
(2,015,000
|
)
|
|||||||||||||
Depreciation
and amortization
|
$
|
53,000
|
$
|
144,000
|
$
|
123,000
|
$
|
4,000
|
$
|
324,000
|
||||||
Amortization
of intangibles
|
$
|
1,733,000
|
$
|
305,000
|
$
|
26,000
|
--
|
$
|
2,064,000
|
|||||||
Goodwill
|
$
|
16,476,000
|
$
|
6,565,000
|
$
|
940,000
|
--
|
$
|
23,981,000
|
|||||||
Total
Assets
|
$
|
97,684,000
|
$
|
15,995,000
|
$
|
4,246,000
|
$
|
1,705,000
|
$
|
119,630,000
|
||||||
Fixed
asset additions
|
$
|
4,000
|
$
|
85,000
|
$
|
11,000
|
$
|
--
|
$
|
100,000
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
||||||||||
Net
sales
|
$
|
5,829,000
|
$
|
3,133,000
|
$
|
--
|
$
|
8,962,000
|
|||||
Cost
of sales
|
4,386,000
|
2,323,000
|
--
|
6,709,000
|
|||||||||
Gross
profit
|
1,443,000
|
810,000
|
--
|
2,253,000
|
|||||||||
Selling,
general and administrative expenses
|
1,087,000
|
414,000
|
475,000
|
1,976,000
|
|||||||||
Income
(loss) from operations
|
356,000
|
396,000
|
(475,000
|
)
|
277,000
|
||||||||
Interest
expense and amortization of
subordinated
debt
issuance costs
|
(127,000
|
) |
(19,000
|
) |
(115,000
|
) |
(261,000
|
) | |||||
Other
income, net
|
--
|
2,000
|
--
|
2,000
|
|||||||||
Income
(loss) before income taxes
|
$
|
229,000
|
$
|
379,000
|
$
|
(590,000
|
)
|
18,000
|
|||||
Income
tax expense
|
(36,000
|
)
|
|||||||||||
Net
loss
|
$
|
(18,000
|
)
|
||||||||||
Depreciation
and amortization
|
$
|
134,000
|
$
|
112,000
|
$
|
130,000
|
$
|
376,000
|
|||||
Amortization
of intangibles
|
$
|
305,000
|
$
|
26,000
|
$
|
--
|
$
|
331,000
|
|||||
Goodwill
|
$
|
6,565,000
|
$
|
940,000
|
$
|
--
|
$
|
7,505,000
|
|||||
Total
assets
|
$
|
17,959,000
|
$
|
5,165,000
|
$
|
549,000
|
$
|
23,673,000
|
|||||
Fixed
asset additions
|
$
|
96,000
|
$
|
177,000
|
$
|
--
|
$
|
273,000
|
|
•
|
|
cyclical
changes in demand for our products and services;
|
|
•
|
|
cyclical
nature of the individual markets in which our customers
operate;
|
|
•
|
|
That
the dollar amount of our backlog, as stated at any given time, is
not
indicative of our future earnings;
|
|
•
|
|
delays
or difficulties related to our projects including additional costs,
reductions in revenues or the payment of liquidated
damages;
|
|
•
|
|
the
effect of our percentage-of-completion accounting
policies;
|
|
•
|
|
changes
in the estimates and assumptions we use to prepare our financial
statements;
|
|
•
|
|
our
ability to obtain surety bonds or other means of credit support for
projects;
|
|
•
|
|
our
ability to obtain waivers or amendments with our lenders or sureties,
or
to collateralize letters of credit or surety bonds upon non-compliance
with covenants in our Credit Facility or surety indemnity
agreements;
|
|
•
|
|
compliance
with certain debt covenants, which as a result, may interfere with
our
ability to successfully execute our business plan;
|
|
•
|
|
our
indebtedness, which could adversely affect our financial condition
and
impair our ability to fulfill our obligations under our financing
arrangements;
|
|
•
|
|
various
legal, regulatory and litigation risk including but not limited to,
class
action lawsuits, regulatory activities and associated periodic reviews
of
the SEC and Public Company Accounting Oversight Board;
|
|
•
|
|
the
nature of our contracts, particularly fixed-price
contracts;
|
|
•
|
|
the
failure to meet schedule or performance requirements of our
contracts;
|
|
•
|
|
our
dependence on subcontractors;
|
|
•
|
|
possible
cost escalations associated with our fixed-price
contracts;
|
|
•
|
|
our
ability to obtain new contracts for large-scale projects and the
timing of
the performance of these contracts;
|
|
•
|
|
The
effect on our reputation and financial exposure due to the failure
of our
partners to perform their contractual obligations;
|
|
•
|
|
our
dependence on a few significant customers;
|
|
•
|
|
delays
and/or defaults in customer payments;
|
|
•
|
|
potential
professional liability, product liability, warranty and other potential
claims, which may not be covered by insurance;
|
|
•
|
|
the
presence of competitors with greater financial resources and the
impact of
competitive products, services and pricing;
|
|
•
|
|
work
stoppages and other labor problems;
|
|
•
|
|
our
liquidity position;
|
|
•
|
|
a
determination to write-off a significant amount of our intangible
assets;
|
|
•
|
|
our
ability to successfully identify, integrate and complete
acquisitions;
|
|
•
|
|
our
failure to attract and retain qualified personnel;
|
|
•
|
|
our
ability to retain key members of our management;
|
|
•
|
|
our
competitors’ ability to develop or otherwise acquire equivalent or
superior technology;
|
|
•
|
|
general
economic conditions;
|
|
•
|
|
future
changes in accounting standards or interpretations;
|
|
•
|
|
inability
to maintain an effective system of internal control, which could
result in
inaccurate reporting of our financial results or an inability to
prevent
fraud;
|
|
•
|
|
provisions
in our articles of incorporation and by-laws and rights agreement
could
make it more difficult to acquire us and may reduce the market price
of
our common stock;
|
|
•
|
|
changes
in the U.S. economy and global markets as a result of terrorists’
actions;
|
|
•
|
|
increases
in employee-related costs and expenses including healthcare and other
employee benefits such as unemployment insurance and workers’
compensation; and
|
|
•
|
|
our
dependency on technology in our operations and the possible impact
of
system and information technology
interruptions.
|
Three
months Ended April 30,
|
|||||||
2007
|
2006
|
||||||
Net
sales
|
|||||||
Power
industry services
|
$
|
43,354,000
|
$
|
--
|
|||
Nutraceutical
products
|
4,949,000
|
5,829,000
|
|||||
Telecom
infrastructure services
|
2,129,000
|
3,133,000
|
|||||
Net
sales
|
50,432,000
|
8,962,000
|
|||||
Cost
of sales
|
|||||||
Power
industry services
|
43,245,000
|
--
|
|||||
Nutraceutical
products
|
4,166,000
|
4,386,000
|
|||||
Telecom
infrastructure services
|
1,843,000
|
2,323,000
|
|||||
Gross
profit
|
1,178,000
|
2,253,000
|
|||||
Selling,
general and administrative expenses
|
4,561,000
|
1,976,000
|
|||||
(Loss)
income from operations
|
(3,383,000
|
)
|
277,000
|
||||
Interest
expense
|
(204,000
|
)
|
(261,000
|
)
|
|||
Other
income, net
|
633,000
|
2,000
|
|||||
(Loss)
income before income taxes
|
(2,954,000
|
)
|
18,000
|
||||
Income
tax benefit (expense)
|
939,000
|
(36,000
|
)
|
||||
Net
loss
|
$
|
(2,015,000
|
)
|
$
|
(18,000
|
)
|
|
Basic
and diluted loss per share
|
$
|
(0.18
|
)
|
$
|
--
|
||
Weighted
average shares outstanding - basic
and
diluted
|
11,094,000
|
3,814,000
|
Three
Months Ended April 30,
|
|||||||
2007
|
2006
|
||||||
unaudited
|
unaudited
|
||||||
Net
sales
|
(Pro
forma)
|
||||||
Power
industry services
|
$
|
43,354,000
|
$
|
10,156,000
|
|||
Nutraceutical
products
|
4,949,000
|
5,829,000
|
|||||
Telecom
infrastructure services
|
2,129,000
|
3,133,000
|
|||||
Net
sales
|
50,432,000
|
19,118,000
|
|||||
Cost
of sales
|
|||||||
General
Power Services
|
43,245,000
|
10,039,000
|
|||||
Nutraceutical
products
|
4,166,000
|
4,386,000
|
|||||
Telecom
infrastructure services
|
1,843,000
|
2,323,000
|
|||||
Gross
profit
|
1,178,000
|
2,370,000
|
|||||
Selling
and general and administrative expenses
|
4,561,000
|
2,614,000
|
|||||
Loss
from operations
|
$
|
(3,383,000
|
)
|
$
|
(244,000
|
)
|
Three
months ended April 30,
|
|||||||
2007
|
2006
|
||||||
Net
loss
|
$
|
(2,015,000
|
)
|
$
|
(18,000
|
)
|
|
Interest
expense and amortization of
Subordinated
debt issuance costs
|
204,000
|
261,000
|
|||||
Tax
(benefit) expense
|
(939,000
|
)
|
36,000
|
||||
Depreciation
and amortization
|
324,000
|
247,000
|
|||||
Amortization
of intangible assets
|
2,064,000
|
331,000
|
|||||
EBITDA
|
$
|
(362,000
|
)
|
$
|
857,000
|
ITEM
2.
|
UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF
|
|
PROCEEDS
|
||
None.
|
||
ITEM
3.
|
DEFAULTS
UPON SENIOR SECURITIES
|
|
None.
|
||
ITEM
4.
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
|
None.
|
||
ITEM
5.
|
OTHER
INFORMATION
|
|
None.
|
||
ITEM
6.
|
EXHIBITS
|
|
Exhibit
No.
|
Title
|
|
Exhibit:
31.1
|
Certification
of Chief Executive Officer, pursuant to Rule
|
|
13a-14(c)
under the Securities Exchange Act of 1934
|
||
Exhibit:
31.2
|
Certification
of Chief Financial Officer, pursuant to Rule
|
|
13a-14(c)
under the Securities Exchange Act of 1934
|
||
Exhibit:
32.1
|
Certification
of Chief Executive Officer, pursuant to
|
|
18
U.S.C. Section 1350
|
||
Exhibit:
32.2
|
Certification
of Chief Financial Officer, pursuant to
|
|
18
U.S.C. Section 1350
|
ARGAN, INC. | ||
|
|
|
June
12, 2007
|
By: | /s/ Rainer Bosselmann |
Rainer Bosselmann |
||
Chairman
of the Board and Chief Executive
Officer
|
|
|
|
June
12, 2007
|
By: | /s/ Arthur F. Trudel |
Arthur F. Trudel |
||
Senior
Vice President, Chief Financial Officer and
Secretary
|